Next Article in Journal
Biomarker-Based Pharmacological Characterization of ENX-102, a Novel α2/3/5 Subtype-Selective GABAA Receptor Positive Allo-Steric Modulator: Translational Insights from Rodent and Human Studies
Previous Article in Journal
Diverse Roles of Tubulin Polymerization Promoting Protein 3 (TPPP3) in Human Health and Disease
Previous Article in Special Issue
Effect of Interventions in WNT Signaling on Healing of Cardiac Injury: A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cells
Volume 14
Issue 20
10.3390/cells14201574
cells-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Cells 2020, 9(10), 2177.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Dallons et al. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells 2020, 9, 2177

by
Matthieu Dallons
,
Esma Alpan
,
Corentin Schepkens
,
Vanessa Tagliatti
and
Jean-Marie Colet
*
Department of Human Biology & Toxicology, Faculty of Medicine and Pharmacy, University of Mons, Place du Parc 20, 7000 Mons, Belgium
*
Author to whom correspondence should be addressed.
Cells 2025, 14(20), 1574; https://doi.org/10.3390/cells14201574
Submission received: 23 September 2025 / Accepted: 29 September 2025 / Published: 10 October 2025
(This article belongs to the Special Issue The Molecular and Cellular Basis of Cardiovascular Disease)
Browse Figure
Versions Notes

Error in Figure 1

In the original publication [1], there was a mistake in Figure 1. Indirect immunofluorescence staining of the GPR91 receptor on H9C2 and MCF-7 cells. The wrong picture for the “secondary AB + DAPI” condition for H9C2 cells was used. The picture used was the same as the “primary AB + secondary AB + DAPI” condition for H9C2 cells, with a different frame and with the blue channel reading only. The corrected figure, Figure 1. Indirect immunofluorescence staining of the GPR91 receptor on H9C2 and MCF-7 cells, appears below.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Dallons, M.; Alpan, E.; Schepkens, C.; Tagliatti, V.; Colet, J.-M. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells 2020, 9, 2177. [Google Scholar] [CrossRef]
Cells 14 01574 g001
Figure 1. Indirect immunofluorescence staining of the GPR91 receptor on H9C2 and MCF-7 cells. Cells were labeled with 4′,6-diamidino-2-phénylindole (DAPI) and rabbit anti-GPR91 antibody (AB) revelated with fluorescent Alexa Fluor 488 secondary AB. A control without primary AB was made for both cell lines.
Figure 1. Indirect immunofluorescence staining of the GPR91 receptor on H9C2 and MCF-7 cells. Cells were labeled with 4′,6-diamidino-2-phénylindole (DAPI) and rabbit anti-GPR91 antibody (AB) revelated with fluorescent Alexa Fluor 488 secondary AB. A control without primary AB was made for both cell lines.
Cells 14 01574 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Dallons, M.; Alpan, E.; Schepkens, C.; Tagliatti, V.; Colet, J.-M. Correction: Dallons et al. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells 2020, 9, 2177. Cells 2025, 14, 1574. https://doi.org/10.3390/cells14201574

AMA Style

Dallons M, Alpan E, Schepkens C, Tagliatti V, Colet J-M. Correction: Dallons et al. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells 2020, 9, 2177. Cells. 2025; 14(20):1574. https://doi.org/10.3390/cells14201574

Chicago/Turabian Style

Dallons, Matthieu, Esma Alpan, Corentin Schepkens, Vanessa Tagliatti, and Jean-Marie Colet. 2025. "Correction: Dallons et al. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells 2020, 9, 2177" Cells 14, no. 20: 1574. https://doi.org/10.3390/cells14201574

APA Style

Dallons, M., Alpan, E., Schepkens, C., Tagliatti, V., & Colet, J.-M. (2025). Correction: Dallons et al. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells 2020, 9, 2177. Cells, 14(20), 1574. https://doi.org/10.3390/cells14201574

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop